BACKGROUND: Cognitive impairment is common sequelae of multiple sclerosis (MS); however, relatively little is known about cognitive impairment in late-onset multiple sclerosis (LOMS). OBJECTIVE: To investigate differences in disease characteristics and cognition in LOMS and adult-onset multiple sclerosis (AOMS) patients. METHODS: Archival medical records and neuropsychological evaluations from an MS specialty center were reviewed. Differences in disease characteristics between 53 LOMS and 124 AOMS were compared using chi-square or analysis of variance (ANOVA). To investigate differences in cognitive functioning, age-adjusted standardized scores were compared via analysis of covariance (ANCOVA), using cardiac risk factors and disease duration as covariates. RESULTS: Compared to AOMS, LOMS patients had significantly more cardiac risk factors, shorter disease duration, and shorter time to diagnosis. LOMS patients had similar Expanded Disability Status Scale scores as AOMS patients. LOMS patients demonstrated significantly more impairment on tasks of visual learning and memory, and working memory than AOMS patients. CONCLUSION: Despite a shorter disease duration, LOMS and AOMS patients had similar levels of physical impairment. However, even after accounting for differences in disease duration and cardiac risk, LOMS patients showed a greater burden of cognitive impairment than AOMS patients, suggesting MS diagnosed later in life may progress faster due to the interaction between MS neuropathology and aging.
BACKGROUND: Cognitive impairment is common sequelae of multiple sclerosis (MS); however, relatively little is known about cognitive impairment in late-onset multiple sclerosis (LOMS). OBJECTIVE: To investigate differences in disease characteristics and cognition in LOMS and adult-onset multiple sclerosis (AOMS) patients. METHODS: Archival medical records and neuropsychological evaluations from an MS specialty center were reviewed. Differences in disease characteristics between 53 LOMS and 124 AOMS were compared using chi-square or analysis of variance (ANOVA). To investigate differences in cognitive functioning, age-adjusted standardized scores were compared via analysis of covariance (ANCOVA), using cardiac risk factors and disease duration as covariates. RESULTS: Compared to AOMS, LOMS patients had significantly more cardiac risk factors, shorter disease duration, and shorter time to diagnosis. LOMS patients had similar Expanded Disability Status Scale scores as AOMS patients. LOMS patients demonstrated significantly more impairment on tasks of visual learning and memory, and working memory than AOMS patients. CONCLUSION: Despite a shorter disease duration, LOMS and AOMS patients had similar levels of physical impairment. However, even after accounting for differences in disease duration and cardiac risk, LOMS patients showed a greater burden of cognitive impairment than AOMS patients, suggesting MS diagnosed later in life may progress faster due to the interaction between MS neuropathology and aging.
Authors: Orhun H Kantarci; Christine Lebrun; Aksel Siva; Mark B Keegan; Christina J Azevedo; Matilde Inglese; Mar Tintoré; Braeden D Newton; Francoise Durand-Dubief; Maria Pia Amato; Nicola De Stefano; Maria Pia Sormani; Daniel Pelletier; Darin T Okuda Journal: Ann Neurol Date: 2015-12-29 Impact factor: 10.422
Authors: Pezhman Roohani; Tenbit Emiru; Adam Carpenter; Christopher Luzzio; Jerome Freeman; Susan Scarberry; Gary Beaver; Lisa Davidson; Gareth Parry Journal: Mult Scler Relat Disord Date: 2014-03-03 Impact factor: 4.339
Authors: F Fazekas; S Strasser-Fuchs; H Kollegger; T Berger; W Kristoferitsch; H Schmidt; C Enzinger; M Schiefermeier; C Schwarz; B Kornek; M Reindl; K Huber; R Grass; G Wimmer; K Vass; K H Pfeiffer; H P Hartung; R Schmidt Journal: Neurology Date: 2001-09-11 Impact factor: 9.910
Authors: John DeLuca; Gordon J Chelune; David S Tulsky; Jean Lengenfelder; Nancy D Chiaravalloti Journal: J Clin Exp Neuropsychol Date: 2004-06 Impact factor: 2.475
Authors: Rebecca J Melrose; Evan Zahniser; Stacy S Wilkins; Joseph Veliz; Arpi S Hasratian; David L Sultzer; Amy M Jimenez Journal: Behav Brain Res Date: 2019-10-31 Impact factor: 3.332
Authors: Hsueh-Sheng Chiang; Alka Khera; Barbara E Stopschinski; Olaf Stuve; John Hart; Brendan Kelley; Trung Nguyen Journal: Geriatrics (Basel) Date: 2022-06-05